Orion Group: 3 Key Takeaways for Long-Term Investors
Orion Group Holdings Announces Conference Participation
Orion Group Holdings, Inc. Appoints Mark A. Handley to Board of Directors, Expanding Board to seven Directors
Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations
Orion Group Holdings (ORN) Stock Price Jumps As Q3 Earnings Revive Profit Debate
Orion Group Holdings Announces New Contract Awards of $250 Million
Orion Group Announces $250M In October Contract Awards And Change Orders
Orion Group Holdings, Inc. 2026 Q3 - Results - Earnings Call Presentation
Orion Group (ORN) Q3 2026 Earnings Call Transcript
Orion Group Holdings, Inc. Reports Third Quarter 2026 Results
What Orion Group (ORN) Said on Its Q3 Earnings Call
Orion Group Holdings, Inc. (ORN) Q3 2026 Earnings Call Transcript
Orion Gr Hldgs Q3 2026 Earnings Call Transcript
Orion Group Holdings (NYSE:ORN) Q3 Beat and Margin Expansion Support Reiterated Guidance
Orion Marine (ORN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Orion Group Holdings Reports Third Quarter 2026 Results
Orion Group Holdings Affirms FY2026 Adj EPS Guidance of $0.23-$0.30 vs $0.25 Est; Affirms FY2026 Sales Guidance of $900.000M-$950.000M vs $930.459M Est
Orion Gr Hldgs Q3 Adj. EPS $0.12 Beats $0.09 Estimate, Sales $256.152M Beat $245.991M Estimate
Orion Group: Q3 Could Go Well, But What Matters Is The 2027 Guidance
JP Morgan Maintains Overweight on Orion Group Holdings, Lowers Price Target to $14
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.